Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,858 | 937 | 98.6% |
| Education | $223.13 | 6 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,763 | 101 | $0 (2024) |
| Novo Nordisk Inc | $1,587 | 95 | $0 (2024) |
| ABBVIE INC. | $1,482 | 95 | $0 (2024) |
| Lilly USA, LLC | $1,329 | 79 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,094 | 68 | $0 (2024) |
| PFIZER INC. | $1,093 | 77 | $0 (2024) |
| Amgen Inc. | $931.15 | 53 | $0 (2024) |
| Astellas Pharma US Inc | $762.57 | 38 | $0 (2024) |
| Merck Sharp & Dohme LLC | $618.66 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $505.92 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,832 | 95 | Lilly USA, LLC ($252.08) |
| 2023 | $2,230 | 116 | ABBVIE INC. ($439.30) |
| 2022 | $2,453 | 136 | Lilly USA, LLC ($337.38) |
| 2021 | $1,592 | 87 | Novo Nordisk Inc ($379.35) |
| 2020 | $1,299 | 84 | AstraZeneca Pharmaceuticals LP ($248.02) |
| 2019 | $2,485 | 146 | Amgen Inc. ($292.18) |
| 2018 | $2,208 | 140 | AstraZeneca Pharmaceuticals LP ($356.01) |
| 2017 | $1,982 | 139 | AstraZeneca Pharmaceuticals LP ($402.84) |
All Payment Transactions
943 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: RESPIRATORY | ||||||
| 12/08/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $107.97 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: PAIN | ||||||
| 11/13/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: Obesity | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Biological | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: VACCINE | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Hematology | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: Obesity | ||||||
| 09/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $30.41 | General |
| Category: Endocrinology | ||||||
| 09/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 3,757 | 5,508 | $655,714 | $322,215 |
| 2022 | 32 | 3,925 | 5,136 | $575,994 | $290,962 |
| 2021 | 37 | 4,856 | 6,286 | $720,062 | $338,399 |
| 2020 | 33 | 5,352 | 6,526 | $717,266 | $312,712 |
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 729 | 1,435 | $246,958 | $123,213 | 49.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 554 | 554 | $95,229 | $71,479 | 75.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 126 | 730 | $85,151 | $34,975 | 41.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 123 | 158 | $41,562 | $21,451 | 51.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 59 | 59 | $27,836 | $15,803 | 56.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 115 | 116 | $13,920 | $8,248 | 59.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 208 | 226 | $24,891 | $5,481 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 94 | $9,568 | $5,470 | 57.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 170 | 171 | $10,044 | $5,146 | 51.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 62 | 120 | $6,600 | $4,478 | 67.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 226 | 226 | $13,500 | $4,219 | 31.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 22 | 22 | $4,591 | $3,585 | 78.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 35 | 35 | $4,585 | $2,653 | 57.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 242 | 249 | $19,655 | $2,467 | 12.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 44 | 46 | $6,900 | $2,263 | 32.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 54 | 54 | $3,096 | $1,620 | 52.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 539 | 676 | $13,535 | $1,475 | 10.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 30 | 34 | $5,100 | $1,338 | 26.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 65 | 103 | $3,863 | $1,272 | 32.9% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 13 | 13 | $4,940 | $1,182 | 23.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 86 | $3,346 | $900.02 | 26.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 45 | 51 | $1,479 | $811.00 | 54.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 57 | 78 | $4,446 | $733.04 | 16.5% |
| 90471 | Administration of vaccine | Office | 2023 | 47 | 50 | $1,500 | $684.60 | 45.6% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 19 | 19 | $570.00 | $558.60 | 98.0% |
About Dr. Michelle Jenkins, M.D
Dr. Michelle Jenkins, M.D is a Family Medicine healthcare provider based in Cumming, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881677458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Jenkins, M.D has received a total of $16,081 in payments from pharmaceutical and medical device companies, with $1,832 received in 2024. These payments were reported across 943 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($15,858).
As a Medicare-enrolled provider, Jenkins has provided services to 17,890 Medicare beneficiaries, totaling 23,456 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cumming, GA
- Active Since 11/28/2005
- Last Updated 03/10/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1881677458
Products in Payments
- FARXIGA (Drug) $1,127
- JARDIANCE (Drug) $1,042
- MOUNJARO (Drug) $615.77
- VRAYLAR (Drug) $553.19
- Ozempic (Drug) $509.84
- JANUVIA (Drug) $378.06
- TRULICITY (Drug) $369.68
- SPRAVATO (Drug) $359.40
- UBRELVY (Drug) $337.84
- Rubraca (Drug) $328.22
- NURTEC ODT (Drug) $319.72
- TRINTELLIX (Drug) $313.40
- Aimovig (Biological) $302.00
- SYMBICORT (Drug) $296.25
- QULIPTA (Drug) $295.95
- Kerendia (Drug) $270.90
- Saxenda (Drug) $267.43
- MYRBETRIQ (Drug) $250.04
- Inspire Upper Airway Stimulation System (Device) $242.34
- Livalo (Drug) $226.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cumming
Charles Decook, Md, MD
Family Medicine — Payments: $27.1M
Dr. Nadine Halliburton-Foster, Md, MD
Family Medicine — Payments: $171,404
Raymond Easley, D.o, D.O
Family Medicine — Payments: $9,775
Jeevana Krishna, M.d, M.D
Family Medicine — Payments: $8,673
Ryan Schott, Pa-C, PA-C
Family Medicine — Payments: $8,211
Dr. Brent Carroll, D.o, D.O
Family Medicine — Payments: $5,693